Physician profile
Marlene Wright
NPI 1215977467
$6,801.29
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,835 · 2022: $2,704 · 2023: $1,262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,163 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,163.42 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,410.24 | 2021-2023 | Otezla |
| Abbvie INC. | $1,149.33 | 2021-2023 | |
| Janssen Biotech, INC. | $856.43 | 2021-2023 | Tremfya, Simponi Aria, Simponi |
| Novartis Pharmaceuticals Corporation | $856.28 | 2021-2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $422.46 | 2021-2023 | Targretin, Siliq |
| Leo Pharma INC. | $422.15 | 2021-2023 | Adbry |
| Ucb, INC. | $377.99 | 2021-2023 | Cimzia |
| Sun Pharmaceutical Industries INC. | $265.56 | 2022 | |
| Pfizer INC. | $225.42 | 2021-2022 | |
| Lilly USA, LLC | $198.07 | 2021-2023 | Taltz, Olumiant |
| E.R. Squibb & Sons, L.L.C. | $174.51 | 2023 | Sotyktu |
| Dermavant Sciences, INC. | $133.68 | 2023 | Vtama |
| Genzyme Corporation | $80.09 | 2021-2022 | |
| Biofrontera INC. | $63.96 | 2021-2022 | |
| Genentech USA, INC. | $63.84 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $29.26 | 2021-2023 | |
| Regeneron Healthcare Solutions, INC. | $26.87 | 2022 | |
| Mission Pharmacal Company | $16.33 | 2021 | |
| Arcutis Biotherapeutics, INC. | $15.52 | 2023 | |
| Incyte Corporation | $13.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marlene Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.